A newly awarded grant from the ALS Association will support Asha Therapeutics' work to advance ASHA-624 into a first-in-human ...

In a first-of-its-kind trial, physicians will review neurofilament test results with patients and decide whether to continue ...

Aimed at patients who are ineligible to take part in other clinical trials due to their advanced stage ALS, the trial hopes ...

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for ...

- VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - ...

has opted to pursue the development of therapeutics against two validated drug targets for amyotrophic lateral sclerosis (ALS ...

amyotrophic lateral sclerosis (ALS). The latter condition – also known as Lou Gehrig’s disease – causes damage to the nerve ...

A new AI-powered interpreter is expected to simulate speakers’ voices in different languages during Microsoft Teams meetings.

Alabama Governor Kay Ivey released a statement following the death of former State Finance Director Kelly Butler.Ivey said ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

The St. Peter’s Hospital ALS Regional Center gives specialized services and resources to people with Amyotrophic Lateral ...